MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
18:55
The German Foreign Minister, Johann Wadephul, announced in Kiev the allocation of 60 million euros for Ukraine, of which 50 million is for humanitarian aid and 10 million for NATO assistance.
18:50
Serena Williams will play in a team with Carlos Alcaraz in the mixed doubles event at the U.S. Open, marking her return to competition after 2022.
18:41
Resumption of medical activity at Fundeni Institute after the rapid extinguishing of a minor fire in a ward
18:34
A car salesman from Belgium became a prince at the age of 26 following a paternity DNA test.
18:25
The Ambassador of Guyana to the UN, Carolyn Rodrigues Birkett, received the most votes in an informal ballot, becoming the favorite for the position of Secretary-General of the organization.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
